These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 358884)

  • 21. Controlled comparison of amikacin and gentamicin.
    Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
    N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of netilmicin in a district general hospital.
    Mummery RV
    Curr Med Res Opin; 1982; 8(2):97-103. PubMed ID: 7105827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and bacteriological evaluation of netilmicin in gram-negative infections.
    Klastersky J; Meunier-Carpentier F; Coppens-Kahan L; Daneau D; Prevost JM
    Antimicrob Agents Chemother; 1977 Oct; 12(4):503-9. PubMed ID: 335960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
    Federspil P; Schätzle W; Tiesler E
    J Infect Dis; 1976 Aug; 134 Suppl():S200-5. PubMed ID: 972282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netilmicin: clinical efficacy, tolerance, and toxicity.
    Panwalker AP; Malow JB; Zimelis VM; Jackson GG
    Antimicrob Agents Chemother; 1978 Feb; 13(2):170-6. PubMed ID: 348092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ototoxicity of the aminoglycoside antibiotics (author's transl)].
    Federspil P
    Infection; 1976; 4(4):239-48. PubMed ID: 1017884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
    Brewer NS
    Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymuria in aminoglycoside-induced kidney damage. Comparative study of gentamicin, amikacin, sisomicin and netilmicin.
    Palla R; Marchitiello M; Tuoni M; Cirami C; Giovannini L; Bertelli AA; Bertelli A
    Int J Clin Pharmacol Res; 1985; 5(5):351-5. PubMed ID: 2866167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative cost effectiveness of gentamicin and tobramycin.
    Holloway JJ; Smith CR; Moore RD; Feroli ER; Lietman PS
    Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Netilmicin (Netromycin, Schering-Plough).
    Guay DR
    Drug Intell Clin Pharm; 1983 Feb; 17(2):83-91. PubMed ID: 6337803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical evaluation of netilmicin therapy in serious infections.
    Jahre JA; Fu KP; Neu HC
    Am J Med; 1979 Jan; 66(1):67-73. PubMed ID: 420253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.
    Lau WK; Young LS; Black RE; Winston DJ; Linne SR; Weinstein RJ; Hewitt WL
    Am J Med; 1977 Jun; 62(6):959-66. PubMed ID: 586099
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
    Bock BV; Edelstein PH; Meyer RD
    Antimicrob Agents Chemother; 1980 Feb; 17(2):217-25. PubMed ID: 6992711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative overview of randomized trials of aminoglycosides.
    Evans DA; Buring J; Mayrent S; Rosner B; Colton T; Hennekens C
    Am J Med; 1986 Jun; 80(6B):39-43. PubMed ID: 3524219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycoside antibiotics in infectious diseases. An overview.
    Siegenthaler WE; Bonetti A; Luthy R
    Am J Med; 1986 Jun; 80(6B):2-14. PubMed ID: 3524216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.